OWC Pharmaceutical Research Corp. (OWCP)
OTCMKTS · Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
At close: Feb 10, 2026

OWCP Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2018FY 2017FY 2016FY 2015FY 2014
Period Ending
Sep '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14
Net Income
1.34-10.26-4.56-2.29-1.65-5.07
Depreciation & Amortization
0.010.010.010.010.010
Other Amortization
-0.48--00.03
Stock-Based Compensation
0.270.812.051.440.374.42
Other Operating Activities
-4.246.271.250.23-0-
Change in Accounts Receivable
-----0.01-
Change in Accounts Payable
0.080.060.03-0.020.010.02
Change in Unearned Revenue
-0.1--0.050.05-
Change in Other Net Operating Assets
-0.10.130.030.050.01-0.01
Operating Cash Flow
-2.74-2.5-1.19-0.53-1.22-0.6
Capital Expenditures
-0.01-0.03-0.01-0-0-0.03
Investing Cash Flow
-0.01-0.03-0.01-0-0-0.03
Short-Term Debt Issued
-----0.01
Long-Term Debt Issued
--0.050.32--
Total Debt Issued
--0.050.32-0.01
Short-Term Debt Repaid
------0.01
Long-Term Debt Repaid
---0.3---
Total Debt Repaid
---0.3---0.01
Net Debt Issued (Repaid)
---0.250.32--
Issuance of Common Stock
-0.111.940.330.090.77
Other Financing Activities
----0.041.33
Financing Cash Flow
-5.021.690.650.122.09
Foreign Exchange Rate Adjustments
-0-0---0.020.01
Miscellaneous Cash Flow Adjustments
------0
Net Cash Flow
-2.752.490.50.12-1.111.47
Free Cash Flow
-2.75-2.53-1.2-0.53-1.22-0.63
Free Cash Flow Margin
----1062.26%--
Free Cash Flow Per Share
-0.01-0.02-0.01-0.01-0.01-0.01
Levered Free Cash Flow
-0.88-0.150.510.24-0.631.25
Unlevered Free Cash Flow
-0.880.360.520.24-0.631.24
Change in Working Capital
-0.120.190.060.080.060.01
Source: S&P Global Market Intelligence. Standard template. Financial Sources.